Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
============================================================================================================================================

* Marion Allouchery
* Thomas Lombard
* Mickael Martin
* Franck Rouby
* Marion Sassier
* Celia Bertin
* Marina Atzenhoffer
* Ghada Miremont-Salame
* Marie-Christine Perault-Pochat
* Mathieu Puyade